eHealth Ventures

Insight Axis uses EEG Analytics proposes to create an algorithm-based platform for predicting the compliance and responsiveness of neuropsychiatric patients to different medications. The platform will enable physicians to predict the patient’s neurobiological response to specific medications before treatment has even begun. The platform will create patient-specific brainwave signatures using data from EEG results. Using this Brain Signature, the algorithm will be able to calculate neuro-markers in the brain and then categorically assess the potential of drug suitability for the individual patient.

Acute Otitis Media (AOM) causes poor conductance of the Chorda Tympani nerve, resulting in its functional impairment, interpreted by the brain as impaired taste sensation. During the inflammation period of AOM, there is a difference in the taste sensation at the two sides of the tongue. While the unaffected side transmits normal taste sensation, on the affected side there is decrease in taste transmission and sensation. The taste buds can be activated with electrical stimulation and the gustatory evoked potentials (GEPs) can be recorded at the cortical gustatory cortex using EEG. Given the observation that AOM is usually unilateral and that the taste sensation on the side of the infection is damaged, electrical stimulation of both sides of the tongue should resulted in different GEPs reading from the infected side compared to the intact side, detecting the presence of AOM. Talma Medical develops a breakthrough innovative technology for accurate clinical diagnostic at home. An over the counter, easy to use and mostly accurate device will make a revolution in the way AOM is diagnosed.